RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Carmen Cadilla to Female

This is a "connection" page, showing publications Carmen Cadilla has written about Female.
Connection Strength

0.246
  1. Su?rez E, Gonz?lez L, P?rez-Mitchell C, Ortiz AP, Ram?rez-Sola M, Acosta J, Bernabe-Dones RD, Gonz?lez-Aquino C, Montes-Rodr?guez I, Cadilla CL. Pathway Analysis using Gene-expression Profiles of HPV-positive and HPV-negative Oropharyngeal Cancer Patients in a Hispanic Population: Methodological Procedures. P R Health Sci J. 2016 Mar; 35(1):3-8.
    View in: PubMed
    Score: 0.037
  2. Jard?n J, Izquierdo NJ, Renta JY, Garc?a-Rodr?guez O, Cadilla CL. Ocular Findings in Patients with the Hermansky-Pudlak Syndrome (Types 1 and 3). Ophthalmic Genet. 2016; 37(1):89-94.
    View in: PubMed
    Score: 0.032
  3. Duconge J, Cadilla CL. CYP2D6's functional status associated with the length of hospitalization stay in psychiatric patients: a twist in the tale or evidence that matters? Biomark Med. 2013 Dec; 7(6):913-4.
    View in: PubMed
    Score: 0.031
  4. Lojo L, Santiago-Borrero P, Rivera E, Renta J, Cadilla CL. Asymptomatic child heterozygous for hemoglobin S and hemoglobin P?rto Alegre. Pediatr Blood Cancer. 2011 Mar; 56(3):458-9.
    View in: PubMed
    Score: 0.025
  5. Santiago Borrero PJ, Rodr?guez-P?rez Y, Renta JY, Izquierdo NJ, Del Fierro L, Mu?oz D, Molina NL, Ram?rez S, Pag?n-Mercado G, Ort?z I, Rivera-Caragol E, Spritz RA, Cadilla CL. Genetic testing for oculocutaneous albinism type 1 and 2 and Hermansky-Pudlak syndrome type 1 and 3 mutations in Puerto Rico. J Invest Dermatol. 2006 Jan; 126(1):85-90.
    View in: PubMed
    Score: 0.018
  6. Garc?a-Garc?a I, Garc?a-Fragoso L, Renta J, Arce S, Cadilla CL. Erythrocyte volume, folate levels, and the presence of methylenetetrahydrofolate reductase polymorphism. P R Health Sci J. 2002 Mar; 21(1):17-9.
    View in: PubMed
    Score: 0.014
  7. Garc?a-Fragoso L, Garc?a-Garc?a I, de la Vega A, Renta J, Cadilla CL. Presence of the 5,10-methylenetetrahydrofolate reductase C677T mutation in Puerto Rican patients with neural tube defects. J Child Neurol. 2002 Jan; 17(1):30-2.
    View in: PubMed
    Score: 0.014
  8. Rivera-Concepci?n J, Acevedo-Canabal J, Bur?s A, Vargas G, Cadilla C, Izquierdo NJ. Bleeding assessment in female patients with the Hermansky-Pudlak syndrome-A case series. Eur J Haematol. 2019 May; 102(5):432-436.
    View in: PubMed
    Score: 0.011
  9. Duconge J, Ramos AS, Claudio-Campos K, Rivera-Miranda G, Berm?dez-Bosch L, Renta JY, Cadilla CL, Cruz I, Feliu JF, Vergara C, Rua?o G. A Novel Admixture-Based Pharmacogenetic Approach to Refine Warfarin Dosing in Caribbean Hispanics. PLoS One. 2016; 11(1):e0145480.
    View in: PubMed
    Score: 0.009
  10. Duconge J, Cadilla CL, Seip RL, Rua?o G. Why admixture matters in genetically-guided therapy: missed targets in the COAG and EU-PACT trials. P R Health Sci J. 2015 Sep; 34(3):175-7.
    View in: PubMed
    Score: 0.009
  11. Rosti RO, Uyguner ZO, Nazarenko I, Bekerecioglu M, Cadilla CL, Ozgur H, Lee BH, Aggarwal AK, Pehlivan S, Desnick RJ. Setleis syndrome: clinical, molecular and structural studies of the first TWIST2 missense mutation. Clin Genet. 2015 Nov; 88(5):489-493.
    View in: PubMed
    Score: 0.008
  12. Ramos AS, Seip RL, Rivera-Miranda G, Felici-Giovanini ME, Garcia-Berdecia R, Alejandro-Cowan Y, Kocherla M, Cruz I, Feliu JF, Cadilla CL, Renta JY, Gorowski K, Vergara C, Rua?o G, Duconge J. Development of a pharmacogenetic-guided warfarin dosing algorithm for Puerto Rican patients. Pharmacogenomics. 2012 Dec; 13(16):1937-50.
    View in: PubMed
    Score: 0.007
  13. Rodriguez-Franco EJ, Cantres-Rosario YM, Plaud-Valentin M, Romeu R, Rodr?guez Y, Skolasky R, Mel?ndez V, Cadilla CL, Melendez LM. Dysregulation of macrophage-secreted cathepsin B contributes to HIV-1-linked neuronal apoptosis. PLoS One. 2012; 7(5):e36571.
    View in: PubMed
    Score: 0.007
  14. Valentin II, Vazquez J, Rivera-Miranda G, Seip RL, Velez M, Kocherla M, Bogaard K, Cruz-Gonzalez I, Cadilla CL, Renta JY, Feliu JF, Ramos AS, Alejandro-Cowan Y, Gorowski K, Rua?o G, Duconge J. Prediction of warfarin dose reductions in Puerto Rican patients, based on combinatorial CYP2C9 and VKORC1 genotypes. Ann Pharmacother. 2012 Feb; 46(2):208-18.
    View in: PubMed
    Score: 0.007
  15. Tukel T, ?o?ic D, Al-Gazali LI, Erazo M, Casasnovas J, Franco HL, Richardson JA, Olson EN, Cadilla CL, Desnick RJ. Homozygous nonsense mutations in TWIST2 cause Setleis syndrome. Am J Hum Genet. 2010 Aug 13; 87(2):289-96.
    View in: PubMed
    Score: 0.006
  16. Izquierdo NJ, Emanuelli A, Izquierdo JC, Garc?a M, Cadilla C, Berrocal MH. Foveal thickness and macular volume in patients with oculocutaneous albinism. Retina. 2007 Nov-Dec; 27(9):1227-30.
    View in: PubMed
    Score: 0.005
  17. Cordova A, Barrios NJ, Ortiz I, Rivera E, Cadilla C, Santiago-Borrero PJ. Poor response to desmopressin acetate (DDAVP) in children with Hermansky-Pudlak syndrome. Pediatr Blood Cancer. 2005 Jan; 44(1):51-4.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support